Pemphigus
19 drugs110,528 FAERS reportsMedDRA PT
GET
/api/v1/reaction/pemphigusReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
DefinitionNLM MeSH D010392
Group of chronic blistering diseases characterized histologically by ACANTHOLYSIS and blister formation within the EPIDERMIS.
Source: U.S. National Library of Medicine — MeSH (Pemphigus)
Drugs reporting Pemphigus (19)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Cortisone6,05650%
- 2Triprolidine12043%
- 3Desoximetasone7,85642%
- 4Pseudoephedrine5,17220%
- 5Diatrizoate5912%
- 6Sarilumab2,76811%
- 7Calcium Gluconate1,23911%
- 8Sulfasalazine7,92310%
- 9Golimumab8,1819.8%
- 10Leflunomide9,1598.9%
- 11Alendronate8,8208.8%
- 12Tocilizumab9,0458.1%
- 13Certolizumab Pegol8,6387.5%
- 14Abatacept8,7316.5%
- 15Formaldehyde46.0%
- 16Hydroxychloroquine8,8385.9%
- 17Cetirizine8,4064.9%
- 18Isopropyl Alcohol1,6484.9%
- 19Diclofenac7,8654.8%
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- Systemic Lupus Erythematosus16 shared · 0.50
- Glossodynia12 shared · 0.46
- Hand Deformity10 shared · 0.45
- Synovitis11 shared · 0.41
- Arthropathy14 shared · 0.34
- Pericarditis6 shared · 0.29
- Wound7 shared · 0.28
- Swelling15 shared · 0.28
- Contraindicated Product Administered10 shared · 0.26
- Joint Swelling16 shared · 0.23
Literature
Recent PubMed references pinned to Pemphigus as a MeSH major topic. About the reaction term itself — not about any specific drug.
- Protocol for evaluating the effects of the intelligent multimodal symptom assessment and response system in patients with pemphigus vulgaris: a randomised controlled trial.BMJ open · 2026 · Chen Y, Wang L, Gao J, et al.PMID 42203270DOI 10.1136/bmjopen-2026-116731
- NK cell hyperactivation drives macrophage repolarization and limits M2 bias in pemphigus vulgaris.Frontiers in immunology · 2026 · Hooda V, Singh A, Khandpur S, et al.PMID 42183286DOI 10.3389/fimmu.2026.1774059
- Genetic and immunological determinants of Pemphigus vulgaris: integrative analysis of HLA-DRB1 and FCGR2B variants.Immunogenetics · 2026 · Kasap BK, Toraman B, Kurt B, et al.PMID 42156579DOI 10.1007/s00251-026-01402-5
- Critical analysis of pemphigus vulgaris in pregnancy.Frontiers in immunology · 2026 · Shah T, Baltabaev A, Geng Y, et al.PMID 41983144DOI 10.3389/fimmu.2026.1788979
- Single-cell sequencing reveals dynamic immune features of paraneoplastic pemphigus in a patient with follicular lymphoma.Frontiers in immunology · 2026 · Wei R, Liu B, Liu Y, et al.PMID 41929499DOI 10.3389/fimmu.2026.1733718
- Predicting Laryngeal Involvement in Pemphigus Vulgaris Using a Clinical Risk Score.JAMA dermatology · 2026 · Ariel D, Tsur N, Mimouni D, et al.PMID 41920571DOI 10.1001/jamadermatol.2026.0391
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.